Clinical Trial Record

Return to Clinical Trials

Impact of Non-magnetic Screen Respiratory Self-guidance During MRI-guided Radiotherapy Sessions for Mobile Lesions


2023-10-16


2025-09-27


2025-09-27


100

Study Overview

Impact of Non-magnetic Screen Respiratory Self-guidance During MRI-guided Radiotherapy Sessions for Mobile Lesions

The patients eligible for the study are those treated by radiotherapy on Linac MRI for a mobile cancerous lesion (pancreas, liver, kidneys, adrenals, lung, adenopathy above or below the diaphragm ...). After signing the consent form, each patient will be randomized to one of two treatment arms: * Standard arm : Radiotherapy treatment with Linac MRI without non-magnetic shielding * Experimental arm : radiotherapy treatment with Linac MRI with non-magnetic screen The aim is to evaluate the effect of using a non-magnetic screen visible to the patient in the bunker during radiotherapy sessions delivered by Linac MRI on decreasing the ratio between the actual treatment time and the treatment time predicted by the machine.

The patients eligible for the study are those treated by radiotherapy on Linac MRI for a mobile cancerous lesion (pancreas, liver, kidneys, adrenals, lung, adenopathy above or below the diaphragm ...). After signing the consent form, each patient will be randomized to one of two treatment arms: * Standard arm : Radiotherapy treatment with Linac MRI without non-magnetic shielding * Experimental arm : radiotherapy treatment with Linac MRI with non-magnetic screen The aim is to compare the effect of the non-magnetic screen on the blocking of the patient's breathing versus the current procedure (the blocking of the breathing is informed by the staff) The patients will each receive 5 sessions of radiotherapy on Linac MRI. 100 patients are expected to participate in this study Before each session will be assessed for anxiety and stress. After each session will be evaluated patient satisfaction, pain intensity and respiratory effort. The duration of the treatment and therefore of the follow-up of the patient in the study is 1 to 2 weeks

  • Patient With Radiotherapy (Linac MRI)
  • Mobile Cancerous Lesion
  • COMBINATION_PRODUCT: With non-magnetic screen
  • 2022-A02774-39

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2023-02-10  

N/A  

2025-02-14  

2023-03-23  

N/A  

2025-02-17  

2023-03-24  

N/A  

2025-02  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
Supportive Care


Allocation:
Randomized


Interventional Model:
Parallel


Masking:
Single


Arms and Interventions

Participant Group/ArmIntervention/Treatment
NO_INTERVENTION: Without Non-magnetic screen

Radiotherapy treatment with Linac MRI without non-magnetic shielding

EXPERIMENTAL: With non-magnetic screen

Radiotherapy treatment with Linac MRI with non-magnetic screen

COMBINATION_PRODUCT: With non-magnetic screen

  • Radiotherapy treatment with Linac MRI is performed with a non-magnetic screen that will guide the patient to block the breathing
Primary Outcome MeasuresMeasure DescriptionTime Frame
The effect of the non-magnetic screen during radiotherapy (Change in ratio of actual treatment time to the treatment time predicted by the machine).To evaluate the effect of a non-magnetic screen visible to the patient in the bunker during radiation therapy sessions delivered by Linac MRI on decreasing the ratio of actual treatment time to the treatment time predicted by the machine.During 25 months
Secondary Outcome MeasuresMeasure DescriptionTime Frame
Patient respiratory effort with visual analog scalePatient respiratory effort for each radiotherapy session according to randomization arm. The scale is graduated from 0 to 10 with 10 = maximum respiratory discomfort and 0 = no respiratory discomfortDuring 25 months
The positional pain with visual analog scaleCompare the positional pain associated with setting up on the treatment table for each radiation therapy session according to the randomization arm. The scale is graduated from 0 to 10 with 0 = absence of pain and 10 = maximum painDuring 25 months
Level of anxiety/stress evaluated with the Spielberg scale via the STAI-Y-form gridTo assess the average level of anxiety/stress for each radiation therapy session according to the randomization arm. The Spielberg scale via the STAI-form Y-A grid is used before each treatment session in order to follow the evolution of the patients' emotional state. 20 questions with 4 possible answers : 1/ Not at all, 2/ A little, 3/Moderately , 4/ A lot.During 25 months
The potential timeEvaluate whether the potential time savings in screen time compensates for the time spent learning the screen during the simulation.During 25 months
The patient satisfaction evaluated with an ad-hoc questionnaire.The patient's satisfaction with his or her involvement in the treatment process will be evaluated at the end of the 5 radiotherapy sessions using an ad-hoc questionnaire.During 25 months

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Name: Gilles TRUC, Doctor

Phone Number: 03 80 73 75 18

Email: gtruc@cgfl.fr

Study Contact Backup

Name: Sophie PARNALLAND, Project Manager

Phone Number: 03 45 34 80 77

Email: sparnalland@cgfl.fr

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Months

Accepts Healthy Volunteers:

    Inclusion Criteria:

  • Patient is at least 18 years old
  • Patient starting radiotherapy on Linac MRI for a mobile cancerous lesion most often in the pancreas, liver, kidneys, adrenals, lung, supra or subdiaphragmatic adenopathy
  • Patient affiliated to the social security system

  • Exclusion Criteria:

  • Patient with lesions not detected by the device's tracking system
  • Patient with visual disturbances
  • Contraindications to treatment with Linac MRI (epileptic patients, pregnant or breastfeeding women, metallic prosthesis or pacemaker not compatible with MRI)
  • Patients with cognitive disorders
  • Persons deprived of liberty or under guardianship (including curatorship)
  • Pregnant or nursing woman
  • Refusal to participate in the study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

No publications available